No title
Next-generation sequencing (NGS) has transformed the study of antibody repertoires by enabling high-throughput, in-depth analysis of immune diversity and antigen-driven selection. When paired with in vitro display technologies, NGS offers unparalleled resolution in characterizing antibody libraries, but also presents substantial computational challenges due to the highly variable nature of antibod
